194 related articles for article (PubMed ID: 34205757)
1. Bioactive Olivacine Derivatives-Potential Application in Cancer Therapy.
Tylińska B; Wiatrak B
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34205757
[TBL] [Abstract][Full Text] [Related]
2. S16020 Pyridocarbazole Derivatives Display High Activity to Lung Cancer Cells.
Chabowska G; Moreira H; Tylińska B; Barg E
Anticancer Agents Med Chem; 2022; 22(13):2419-2428. PubMed ID: 34906061
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Activity of New Olivacine Derivatives.
Piasny J; Wiatrak B; Dobosz A; Tylińska B; Gębarowski T
Molecules; 2020 May; 25(11):. PubMed ID: 32481577
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
[TBL] [Abstract][Full Text] [Related]
5. Lysosomal Exocytosis of Olivacine on the Way to Explain Drug Resistance in Cancer Cells.
Wiatrak B; Gębarowski T; Czwojdziński E; Gąsiorowski K; Tylińska B
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682799
[TBL] [Abstract][Full Text] [Related]
6. Effect of new olivacine derivatives on p53 protein level.
Gębarowski T; Wiatrak B; Gębczak K; Tylińska B; Gąsiorowski K
Pharmacol Rep; 2020 Feb; 72(1):214-224. PubMed ID: 32016852
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytotoxicity of S16020-2, a new olivacine derivative.
Léonce S; Perez V; Casabianca-Pignede MR; Anstett M; Bisagni E; Pierré A; Atassi G
Invest New Drugs; 1996; 14(2):169-80. PubMed ID: 8913838
[TBL] [Abstract][Full Text] [Related]
8. S16020-2, a new highly cytotoxic antitumor olivacine derivative: DNA interaction and DNA topoisomerase II inhibition.
Le Mée S; Pierré A; Markovits J; Atassi G; Jacquemin-Sablon A; Saucier JM
Mol Pharmacol; 1998 Feb; 53(2):213-20. PubMed ID: 9463478
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity evaluation of olivacine-indole hybrids tethered by alkyl linkers.
Pis Diez CM; Céspedes M; Di Venosa GM; Calvo G; Avigliano E; Casas AG; Palermo JA
Nat Prod Res; 2022 Jul; 36(14):3657-3664. PubMed ID: 33517779
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
[TBL] [Abstract][Full Text] [Related]
11. In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts.
Vassal G; Merlin JL; Terrier-Lacombe MJ; Grill J; Parker F; Sainte-Rose C; Aubert G; Morizet J; Sévenet N; Poullain MG; Lucas C; Kalifa C
Cancer Chemother Pharmacol; 2003 May; 51(5):385-94. PubMed ID: 12736760
[TBL] [Abstract][Full Text] [Related]
12. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
[TBL] [Abstract][Full Text] [Related]
13. Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: importance of the N-[2(Dimethylamino)ethyl]carbamoyl side chain.
Le Mée S; Chaminade F; Delaporte C; Markovits J; Saucier JM; Jacquemin-Sablon A
Mol Pharmacol; 2000 Oct; 58(4):709-18. PubMed ID: 10999940
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxic activity of hydroxylated derivatives of olivacine in relation with their biotransformation.
Maftouh M; Besselievre R; Monsarrat B; Lesca P; Meunier B; Husson HP; Paoletti C
J Med Chem; 1985 Jun; 28(6):708-14. PubMed ID: 4009591
[TBL] [Abstract][Full Text] [Related]
15. The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis.
Maggiorella L; Frascogna V; Poullain MG; Berlion M; Lucas C; Razy SD; Eschwege F; Bourhis J
Clin Cancer Res; 2001 Jul; 7(7):2091-5. PubMed ID: 11448928
[TBL] [Abstract][Full Text] [Related]
16. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship analysis of new olivacine derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Kłopotowska D; Filip B; Wietrzyk J
Acta Pol Pharm; 2010; 67(5):495-502. PubMed ID: 20873417
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure, and cytostatic properties of new olivacine derivatives.
Jasztold-Howorko R; Croisy A; Carrez D; Jaroszewicz I; Nasulewicz A; Pełczyńska M; Opolski A
Arch Pharm (Weinheim); 2004 Nov; 337(11):599-604. PubMed ID: 15543533
[TBL] [Abstract][Full Text] [Related]
19. Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole.
Glomb T; Szymankiewicz K; Świątek P
Molecules; 2018 Dec; 23(12):. PubMed ID: 30567416
[TBL] [Abstract][Full Text] [Related]
20. Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines.
Pierré A; Léonce S; Pérez V; Atassi G
Cancer Chemother Pharmacol; 1998; 42(6):454-60. PubMed ID: 9788571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
